By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: Information on the total number of voting rights and shares
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health

Information on the total number of voting rights and shares

GlobeNews Wire
Last updated: 24/05/2025 2:52 AM
GlobeNews Wire
Share
1 Min Read
Information on the total number of voting rights and shares
SHARE
Information on the total number of voting rights and shares

Information on the total number of voting rights and shares

Mont-Saint-Guibert (Belgium), May 23, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.

  • Share capital: EUR 6,430,026.16
  • Total number of securities carrying voting rights: 37,429,265 (all ordinary shares)
  • Total number of voting rights (= denominator): 37,429,265 (all relating to ordinary shares) 
  • Number of rights to subscribe to securities carrying voting rights not yet issued: 2,854,068 (all granted subscription rights; this number excludes 478,057 subscription rights that were issued but not yet granted)

*

*        *

Contact:
Nyxoah
John Landry, CFO
IR@nyxoah.com

  • 2025 05 23 – Press release – Number of shares (ENG)

You Might Also Like

Beko Secures Science Based Targets initiative (SBTi) Validation for 1.5C Aligned Near-Term and Net-Zero Targets

69% of Organizations Breached by Ransomware Over Past Year, Delinea Report Finds

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Feel comfort, find calm: ASICS introduces the new GELKAYANO 32 shoe

TAGGED: pm etaccordanceBE0974358906belgiumbrusselsBrussels:NYXHdisclosureeuronextfollowinginformationissuelargelawmaymontsaintguibertnasdaq nyxhNasdaq:NYXHnumbernyxoahpm cetpublishesrightsshareholdingssharestotalvoting

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
Next Article Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
Health 23/06/2025
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Health 23/06/2025
Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift
Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift
Health 23/06/2025
Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows
Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows
Health 23/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?